Curcumin attenuates lupus nephritis upon interaction with regulatory T cells in New Zealand Black/White mice

British Journal of Nutrition

Volumn 110, Issue 1, 2013, Pages 69-76

  Lee, Hyojung ^a   Kim, Hyunseong ^a   Lee, Gihyun ^a   Chung, Hwan Suck ^a   Bae, Hyunsu ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Autoimmunity; Curcumin; Lupus nephritis; New Zealand Black White F1 mice; Regulatory T cells

Indexed keywords

CURCUMIN; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GLOMERULUS; HELPER CELL; IMMUNE COMPLEX DEPOSITION; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY PARENCHYMA; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NEPHRITIS; NEW ZEALAND; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEINURIA; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; TH1 CELL; TH2 CELL; THERAPY EFFECT;

ANIMALS; ANTIBODIES; ANTIBODIES, ANTINUCLEAR; ANTIGEN-ANTIBODY COMPLEX; CURCUMA; CURCUMIN; DIETARY SUPPLEMENTS; FEMALE; IMMUNOGLOBULIN G; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; MICE; MICE, INBRED NZB; PHYTOTHERAPY; PLANT EXTRACTS; PROTEINURIA; T-LYMPHOCYTES, REGULATORY;

MUS;

EID: 84879228199     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512004734     Document Type: Article

References (29)

1. Swaak AJ, van den Brink HG, Smeenk RJ, et al. (1999) Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology (Oxford, England) 38, 953-958.
2. Agrawal N, Chiang LK & Rifkin IR (2006) Lupus nephritis. Semin Nephrol 26, 95-104.
3. Mason LJ & Berden JH (2008) Pathogenic factors for the development of lupus nephritis. Lupus 17, 251-255.
4. Mortensen ES, Fenton KA & Rekvig OP (2008) Lupus nephritis: the central role of nucleosomes revealed. Am J Pathol 172, 275-283.
5. Bagavant H & Fu SM (2009) Pathogenesis of kidney disease in systemic lupus erythematosus. Curr Opin Rheumatol 21, 489-494.
6. Chan OT, Madaio MP & Shlomchik MJ (1999) The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev 169, 107-121.
7. Wofsy D & Seaman WE (1985) Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med 161, 378-391.
8. Houssiau FA (2004) Management of lupus nephritis: an update. J Am Soc Nephrol 15, 2694-2704.
9. Raimondi G, Turner MS, Thomson AW, et al. (2007) Naturally occurring regulatory T cells: recent insights in health and disease. Crit Rev Immunol 27, 61-95.
10. Sakaguchi S, Ono M, Setoguchi R, et al. (2006) Foxp3\+ CD25\+ CD4\+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212, 8-27.
11. Nishimura E, Sakihama T, Setoguchi R, et al. (2004) Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3\+ CD25\+ CD4\+ regulatory T cells. Int Immunol 16, 1189-1201.
12. Minami R, Sakai K, Miyamura T, et al. (2006) [The role of CD4\+ CD25\+ regulatory T cells in patients with rheumatoid arthritis]. Nihon Rinsho Meneki Gakkai Kaishi 29, 37-42.
13. Viglietta V, Baecher-Allan C, Weiner HL, et al. (2004) Loss of functional suppression by CD4\+ CD25\+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199, 971-979.
14. Alvarado-Sanchez B, Hernandez-Castro B, Portales-Perez D, et al. (2006) Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 27, 110-118.
15. Ammon HP & Wahl MA (1991) Pharmacology of Curcuma longa. Planta Med 57, 1-7.
16. Natarajan C & Bright JJ (2002) Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J Immunol 168, 6506-6513.
17. Sugimoto K, Hanai H, Tozawa K, et al. (2002) Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 123, 1912-1922.
18. Khajehdehi P, Zanjaninejad B, Aflaki E, et al. (2012) Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study. J Ren Nutr 22, 50-57.
19. Foster MH (1999) Relevance of systemic lupus erythematosus nephritis animal models to human disease. Semin Nephrol 19, 12-24.
20. Limtrakul P, Lipigorngoson S, Namwong O, et al. (1997) Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Lett 116, 197-203.
21. Hori S, Nomura T & Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061.
22. Szabo SJ, Kim ST, Costa GL, et al. (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655-669.
23. Yamashita M, Ukai-Tadenuma M, Miyamoto T, et al. (2004) Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci. J Biol Chem 279, 26983-26990.
24. Ando DG, Sercarz EE & Hahn BH (1987) Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model. J Immunol 138, 3185-3190.
25. Stevens TL, Bossie A, Sanders VM, et al. (1988) Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334, 255-258.
26. Fontenot JD, Gavin MA & Rudensky AY (2003) Foxp3 programs the development and function of CD4\+ CD25\+ regulatory T cells. Nature Immunol 4, 330-336.
27. Sakaguchi S, Sakaguchi N, Asano M, et al. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155, 1151-1164.
28. Wolf D, Hochegger K, Wolf AM, et al. (2005) CD4\+ CD25\+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol 16, 1360-1370.
29. Hayashi T, Hasegawa K & Adachi C (2005) Elimination of CD4(\+)CD25(\+) T cell accelerates the development of glomerulonephritis during the preactive phase in autoimmuneprone female NZB £ NZW F mice. Int J Exp Pathol 86, 289-296.